Search Close Search
Search Close Search
Page Menu

UMass Chan Medical School strives to catalyze our world-class basic research into scientific discoveries with high impact clinical applications and overcome the barriers in translating knowledge into clinical practice.

Established in 1970, UMass Chan has rapidly grown into a highly productive, highly collaborative research enterprise with outstanding scientific resources and facilities. UMass Chan receives more than $300 million per year in research funding. Our research community includes a Nobel laureate, a Lasker award recipient, seven National Academy members and four Howard Hughes Medical Institute investigators. Our research achievements have impacted the lives of children and adults in the U.S. and across the globe.

Research news

Getting Results…
  • New UMass Chan study finds geographic variations in use of drugs for nursing home patients with dementia

    New UMass Chan study finds geographic variations in use of drugs for nursing home patients with dementia

    A study by UMass Chan researchers on variations in medications used in nursing homes for patients with Alzheimer’s and other dementias found that antidementia drug use varied by geographic region, while use of antipsychotics was associated with poorer nursing home quality and patient factors.

    Read more
  • Companion papers on immune response spotlight innovative research by MD/PhD student

    Companion papers on immune response spotlight innovative research by MD/PhD student

    The two published papers both started with a single question: “What regulates the immune response in C. elegans?”

    Read more
  • UMass Chan researchers share challenges, potential hope for discussing COVID-19 vaccines with hesitant patients

    UMass Chan researchers share challenges, potential hope for discussing COVID-19 vaccines with hesitant patients

    Discussing the COVID-19 vaccine with vaccine-hesitant patients can be frustrating, a focus group of primary care providers reported in a recent study led by Kimberly Fisher, MD. But having the vaccine available in the clinic, as well as incorporating motivational interviewing techniques, may offer a way forward.  

    Read more
  • UMass Chan researchers develop dual therapeutic that holds promise as pancreatic cancer treatment

    UMass Chan researchers develop dual therapeutic that holds promise as pancreatic cancer treatment

    UMass Chan Medical School scientists Marcus Ruscetti, PhD, and Prabhani Atukorale, PhD, have developed a new, dual immunotherapy approach that may potentially change the way clinicians treat pancreatic cancer.  

    Read more
  • UMass Chan Early Independence Fellows program aims to develop future top investigators

    UMass Chan Early Independence Fellows program aims to develop future top investigators

    Two new donor-funded fellowships are being launched this year at UMass Chan to recruit recent postdoctoral scientists and, through intensive mentoring and resource support, foster their development as independent investigators. The fellowships align with the vision embodied in The Morningside Foundation’s transformational $175 million gift in 2021.  

    Read more
  • UMass Chan scientist Shan Lu reports on effectiveness of DNA vaccine to prevent HIV

    UMass Chan scientist Shan Lu reports on effectiveness of DNA vaccine to prevent HIV

    Shan Lu MD, PhD, co-authored a pair of studies related to the Phase I clinical trial of a polyvalent DNA/prime-protein boost vaccine to prevent HIV, marking the latest step in a decades long quest to harness the power of DNA vaccines to address a major global health need.  

    Read more